Cite
Letter to the Editor in response to "N Folschweiller, V Berlaimont, SR Skinner, CM Wheeler, N Karkada, F Struyf, M Ryser. Letter to the Editor in response to O.M. Bautista, A. Luxembourg. Deconstructing the measure of vaccine efficacy against disease irrespective of HPV in HPV vaccine clinical trials. Contemp. Clin. Trials (2016), doi: 10.1016/j.cct.2016.12.022".
MLA
Bautista, Oliver M., and Alain Luxembourg. “Letter to the Editor in Response to ‘N Folschweiller, V Berlaimont, SR Skinner, CM Wheeler, N Karkada, F Struyf, M Ryser. Letter to the Editor in Response to O.M. Bautista, A. Luxembourg. Deconstructing the Measure of Vaccine Efficacy against Disease Irrespective of HPV in HPV Vaccine Clinical Trials. Contemp. Clin. Trials (2016), Doi: 10.1016/j.Cct.2016.12.022.’” Contemporary Clinical Trials, vol. 54, Mar. 2017, p. 105. EBSCOhost, https://doi.org/10.1016/j.cct.2017.01.010.
APA
Bautista, O. M., & Luxembourg, A. (2017). Letter to the Editor in response to “N Folschweiller, V Berlaimont, SR Skinner, CM Wheeler, N Karkada, F Struyf, M Ryser. Letter to the Editor in response to O.M. Bautista, A. Luxembourg. Deconstructing the measure of vaccine efficacy against disease irrespective of HPV in HPV vaccine clinical trials. Contemp. Clin. Trials (2016), doi: 10.1016/j.cct.2016.12.022.” Contemporary Clinical Trials, 54, 105. https://doi.org/10.1016/j.cct.2017.01.010
Chicago
Bautista, Oliver M, and Alain Luxembourg. 2017. “Letter to the Editor in Response to ‘N Folschweiller, V Berlaimont, SR Skinner, CM Wheeler, N Karkada, F Struyf, M Ryser. Letter to the Editor in Response to O.M. Bautista, A. Luxembourg. Deconstructing the Measure of Vaccine Efficacy against Disease Irrespective of HPV in HPV Vaccine Clinical Trials. Contemp. Clin. Trials (2016), Doi: 10.1016/j.Cct.2016.12.022.’” Contemporary Clinical Trials 54 (March): 105. doi:10.1016/j.cct.2017.01.010.